Lecture Notes

Lec # Topics
Part One: Foundations of Bio-Medical Ethics and Modern "Bio-Politics"
1 Section One: Introduction: Bio-Medical Ethics and Bio-Politics: From Clinical Practice and Medical Research to Crisis of Medical Humanitarianism in the Field (PDF)
2

Section Two: Principles of Ethical Medical Practice and Research: Autonomy, Justice, Beneficence, and Nonmaleficience (PDF)

What is Bio-Medical Ethics?

3-4 Section Three: Competing Discourses on Bioethics and Bio-Medical Practice - Anthropology, Feminism, Theology, and Law (PDF)
5-7 Section Four: The Creation of Doctors and the Clinical Gaze or "Whose Body Is It, Anyway?" (PDF 1) (PDF 2) (PDF 3)
8-9 Section Five: Ethical Issues in the Practice of Medicine: Confidentiality and Disclosure; Patient Autonomy and Informed Consent (PDF 1) (PDF 2)
10-11 Section Six: Dilemmas of Public Health Practice: The Limits of Resources and its Allocation (PDF 1) (PDF 2)
Part Two: Medical Technologies, the Body and the State
12-13 Section Seven: Medical Research and Ethical Medical Experimentation - from Eugenics to Anti-Retroviral Drug Trials (PDF 1) (PDF 2)
14-15 Section Eight: Race, Contraception and Family Planning: Contemporary Eugenics? (PDF 1) (PDF 2)
Part Three: Globalizing Bioethics - The Politics of Reproduction
16-17 Section Nine: The Politics of Gender, Reproductive Technologies and Family Planning across Cultures (PDF 1) (PDF 2)
18 Section Ten: Infertility, Assisted Reproduction, Kinship, and Citizenship across Cultures (PDF)
19-20

Section Eleven: State Politics of Human Genetic Engineering, Stem Cell Research, Cloning, and "Surplus Embryos" (PDF 1) (PDF 2)

Lecture 20

Guest Speaker: Dr. James Sherley, MIT Assoc. Professor of Biological Engineering

Part Four: Playing God? Life, Death, Bodies, and Spirits
21-24 Section Twelve: Organ Transplantation, End of Life Issues, and Death across Cultures (PDF 1) (PDF 2) (PDF 3) (PDF 4)
Part Five: Human Rights, Infectious Disease, and the Global Medical Commons
25-26 Section Thirteen: Clinical Dilemmas, Public Health, and Global Pharmaceuticals (PDF 1) (PDF 2)